Clinical Trial Update: Study to Evaluate the Safety, Efficacy of Tegoprazan for the Prevention of PUD in Patients on Treatment With NSAIDs [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the safety and efficacy of tegoprazan to prevent peptic ulcers in patients taking NSAIDs is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peptic Ulcer Disease

Drugs mentioned

• Tegoprazan (tegoprazan)

Snippet

Sponsor: HK inno.N Corporation | Conditions: Preventive Peptic Ulcer | Phase 3 | Status: UNKNOWN